V I S I T
W O R L D ’ S C L I N I C A L L A B O R AT O R Y N E W S L E A D E R ISSN 1068-1760
Vol. 34 No. 5 • 8-9/ 2017
DAILY CLINICAL LAB NEWS
®
I
N
T
E
Blood Test Predicts Vaccine Immunogenicity blood test early after vaccination can predict whether vaccines based on living, modified viruses have had the desired effect within seven days of vaccination. A new study on systems analysis of immune responses induced by a highly promising vaccine against Ebola, as a couple of possible vaccines
A
R
N
A
T
I
O
New Technique Tests Therapies For Cancer Metastasis new laboratory technique can rapidly test the effectiveness of treatments for life-threatening, breast cancer metastases in bone. Until now, there has not been an effective laboratory platform to study metastatic tumors in their new microenvironment. In the clinic, primary breast tumors are usually surgically removed
A
soon after diagnosis, leaving patients “tumor-free.” However, 20% to 40% of breast cancer survivors will eventually suffer metastasis to distant organs, sometimes years after surgery. To mimic the interactions between metastatic breast cancer cells and bone cells in a living system, a test has been developed, called bone-in
Cont’d on page 11
Cont’d on page 11
Image: Courtesy of Thermo Fisher Scientific
Clinical Mass Spectrometry Comes of Age: World's First Fully-Integrated Analyzer A
S
I
T
LINKXPRESS COM R E A D E R
S E R V I C E
®
P O R T A L
Renew /Start your Free Subscription Access Interactive Digital Magazine Instant Online Product Information:
on LinkXpress.com 2 Click to reach reader service portal
novel rapid assay applies a nicking-enzyme amplification reaction to easily and rapidly detect respiratory syncytial virus (RSV) in children hospitalized with acute respiratory-tract infections. Respiratory syncytial virus is a common
A
Cont’d on page 4
DiaSorin to Acquire Siemens' ELISA Immunodiagnostics Business
code(s) of interest on 3 Mark LinkXpress inquiry matrix ®
If your subscription is not renewed every 12 months your Free Subscription may be automatically discontinued
iaSorin S.p.A. (Saluggia, Italy; www.diasorin.com) has entered into an agreement to acquire Siemens Healthineers’ (Erlangen, Germany; www.healthcare. siemens.com) micro-titre-based ELISA immunodiagnostic business portfolio and related tangible and intangible assets, including customer
D
here is an urgent need to develop biomarker strategies to a priori identify castration-resistant prostate cancer (CRPC) patients who will derive minimal benefit from androgen receptor (AR) targeting and offer them an alternative treatment paradigm. The androgen receptor is known to play an important role in helping cancers to become resistant to treatment with abiraterone and enzalutamide, which are standard treatments for
T
ealthcare professionals should consider a person’s blood group when assessing their cardiovascular risk as people with A, B, and AB blood types may be at greater risk of cardiovascular events, particularly heart attacks, than individuals with O blood types. There are some risk factors for heart attack that can be addressed, such as a poor diet, lack of exercise, and smoking. However, some heart Cont’d on page 6
INSIDE
Novel Assay Detects RSV in Children
®
Test Predicts Benefit of Targeted Cancer Treatments
H
Image: Product demonstration at AACC Clinical Lab Expo 2017
Identify LinkXpress codes of 1 interest as you read magazine
L
Blood Group May Affect Heart Attack Risk
See article on page 4
I
A
Cont’d on page 9
next-generation diagnostic system brings together the convenience of clinical analyzers with the selectivity and sensitivity of liquid chromatography-tandem mass spectrometry (LC-MS/MS). The fullyautomated Cascadion SM clinical analyzer may be operated by lab staff with no special training in the technology.
V
N
sales and distribution contracts, installed base of instruments and relevant intellectual property. DiaSorin develops, produces and markets reagent kits for IVD worldwide, and offers a broad range of specialty tests in the immunodiagnostics Cont’d on page 33
Clinical News . . . . . . . . . 4-26 IFCC News . . . . . . . . . . . . . 27 Product News . . . . . . . 14-26 Industry News . . . . . . . . . .33 International Calendar . . . 34 PUBLISHED IN COOPERATION WITH
International Federation of Clinical Chemistry and Laboratory Medicine
GLOBETECH >>> M E D I A <<<